BRTX vs FTNT · rev $401.0K vs P/E 56, rev $6.80B
BioRestorative Therapies Inc (BRTX) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
BRTX currently screens at market cap $10.2M. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the BRTX and FTNT stock pages for the full models.
Not investment advice.